BEDUA Trademark

Trademark Overview

On Monday, February 1, 2016, a trademark application was filed for BEDUA with the United States Patent and Trademark Office. The USPTO has given the BEDUA trademark a serial number of 86892634. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 16, 2019. This trademark is owned by Glaxo Group Limited. The BEDUA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
bedua

General Information

Serial Number86892634
Word MarkBEDUA
Filing DateMonday, February 1, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 16, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Translation of Words in MarkThe wording "BEDUA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 4, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, September 16, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 16, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2019EXTENSION 5 GRANTED
Saturday, February 16, 2019EXTENSION 5 FILED
Wednesday, April 24, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 26, 2019NOTICE OF REVIVAL - E-MAILED
Tuesday, March 26, 2019EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, March 26, 2019PETITION TO REVIVE-GRANTED
Tuesday, March 26, 2019TEAS PETITION TO REVIVE RECEIVED
Monday, March 25, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 25, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 24, 2018EXTENSION 4 GRANTED
Tuesday, July 24, 2018EXTENSION 4 FILED
Tuesday, July 24, 2018TEAS EXTENSION RECEIVED
Thursday, February 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2018EXTENSION 3 GRANTED
Tuesday, February 13, 2018EXTENSION 3 FILED
Tuesday, February 13, 2018TEAS EXTENSION RECEIVED
Saturday, July 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 13, 2017EXTENSION 2 GRANTED
Thursday, July 13, 2017EXTENSION 2 FILED
Thursday, July 13, 2017TEAS EXTENSION RECEIVED
Friday, February 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 8, 2017EXTENSION 1 GRANTED
Wednesday, February 8, 2017EXTENSION 1 FILED
Wednesday, February 8, 2017TEAS EXTENSION RECEIVED
Tuesday, August 16, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 18, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 17, 2016ASSIGNED TO EXAMINER
Thursday, February 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 4, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

bedua pharmaceutical treatment disorders preparations substances diseases hepatological ophthalmic oncological dysfunction